Form 4: Establishment Labs Director Acquires Shares in Lieu of Cash Retainer

Director Bryan Slotkin acquired 398 common shares of Establishment Labs Holdings Inc. in lieu of a quarterly cash retainer payment on March 31, 2025.

Summary

• On March 31, 2025, Bryan Slotkin, a director of Establishment Labs Holdings Inc., acquired 398 common shares.
• The shares were received in lieu of a quarterly cash retainer payment.
• The acquisition was made under the Issuer's Outside Director Compensation Policy and the 2018 Equity Incentive Plan.
• The price per share was $40.81, based on the closing price on the last trading day of the quarter.
• Following the transaction, Slotkin beneficially owns 25,559 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to director compensation. The director taking shares instead of cash is a mildly positive signal.

Positives

• The director's decision to take shares instead of cash may signal confidence in the company's future performance.

Industry Context

Directors often receive equity as part of their compensation, aligning their interests with those of shareholders. This is a common practice in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages vary widely across the industry, but equity-based compensation is a common component.
• Comparing Establishment Labs' director compensation policy to that of similar companies in the medical aesthetics sector would provide further context.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.

Key Dates

Keywords

Establishment Labs, ESTA, Director, Bryan Slotkin, Share Acquisition, Form 4, Equity Incentive Plan, Director Compensation